Empliciti

Active Ingredient(s): Elotuzumab
FDA Approved: * November 30, 2015
Pharm Company: * BRISTOL MYERS SQUIBB
Category: Cancer

Elotuzumab, sold under the brand name Empliciti, is a humanized IgG1 monoclonal antibody medication used in combination with lenalidomide and dexamethasone, for adults that have received 1 to 3 prior therapies for the treatment of multiple myeloma.[1] It is also indicated for adult patients in combination with pomalidomide and dexamethasone, who have received 2 prior therapies including lenalidomide and a protease inhibitor.[1] Administration of elotuzumab is d... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Empliciti 300 mg Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 0003-2291

Labeler:

E.r. Squibb & Sons, L.L.C.

Empliciti 400 mg Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 0003-4522

Labeler:

E.r. Squibb & Sons, L.L.C.